Cite
HARVARD Citation
Moura, C. et al. (2019). Use of disease-modifying anti-rheumatic or anti-tumour necrosis factor drugs and risk of hospitalized infection in ankylosing spondylitis. Scandinavian journal of rheumatology. pp. 121-127. [Online].